1 / 11

New Anticancer Targeted Therapy

New Anticancer Targeted Therapy. Adelaida M rombo, Pharm.D C andidate 2019. Abemaciclib (Verzenio). Apalutamide (Erleada). B evacizumab- awwb (Mvasi)[ Biosimilar of Avastin ]. Dacomitinib (Vizimpro). Durvalumab (Imfinzi). Duvelisib (Copktra ). Encorafenib (Braftovi).

rock
Download Presentation

New Anticancer Targeted Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. New Anticancer Targeted Therapy Adelaida Mrombo, Pharm.D Candidate 2019

  2. Abemaciclib (Verzenio)

  3. Apalutamide (Erleada)

  4. Bevacizumab-awwb (Mvasi)[Biosimilar of Avastin]

  5. Dacomitinib (Vizimpro)

  6. Durvalumab (Imfinzi)

  7. Duvelisib (Copktra)

  8. Encorafenib (Braftovi)

  9. Lorlatinib (Lorbrena)

  10. Talazoparib (Talzenna)

  11. References • Abemaciclib. In: Lexi-Drugs [database on the Internet]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2018 [updated 2018 Nov 16, cited 2018 Nov 14]. • Apalutamide (Erleada) [Internet]. Silver Spring [MD]: US Food and Drug Administration; 2018 [cited 2018 Nov 14]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210951s000lbl.pdf • Bevacizumab-awwb. In: Lexi-Drugs [database on the Internet]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2018 [updated 2018 Nov 16, cited 2018 Nov 14]. • Dacomitinib (Vizimpro) [Internet]. Silver Spring [MD]: US Food and Drug Administration; 2018 [cited 2018 Nov 14]. Available from:https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf • Encorafenib (Braftovi) [Internet]. Silver Spring [MD]: US Food and Drug Administration; 2018 [cited 2018 Nov 14]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210496lbl.pdf • Duvelisib. In: Lexi-Drugs [database on the Internet]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2018 [updated 2018 Nov 15, cited 2018 Nov 14]. • Durvalumab. In: Lexi-Drugs [database on the Internet]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2018 [updated 2018 Nov 15 , cited 2018 Nov 14]. • Lorlatinib. In: Lexi-Drugs [database on the Internet]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2018 [updated 2018 Nov 14, cited 2018 Nov 14]. • Talzenna (Talazoparib) [Internet]. Silver Spring [MD]: US Food and Drug Administration; 2018 [cited 2018 Nov 15]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211651s000lbl.pdf

More Related